The impact of comorbidities in patients with spondyloarthritis
- PMID: 37394891
- DOI: 10.1111/1756-185X.14682
The impact of comorbidities in patients with spondyloarthritis
References
REFERENCES
-
- Ma KS, Lee YH, Lin CJ, et al. Management of extra-articular manifestations in spondyloarthritis. Int J Rheum Dis. 2023;26(2):183-186. doi:10.1111/1756-185X.14485
-
- Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology. 2020;59:iv47-iv57.
-
- Shen J, Wong KT, Cheng IT, et al. Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. Ann Rheum Dis. 2017;76(6):1237-1244.
-
- Conrad N, Verbeke G, Molenberghs G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733-743.
-
- Pina Vegas L, Sbidian E, Penso L, et al. Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database. Rheumatology (Oxford). 2021;60(3):1243-1251.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources